- Publications
- Influence
Share This Author
Gallium in cancer treatment.
- P. Collery, B. Keppler, C. Madoulet, B. Desoize
- Biology, ChemistryCritical reviews in oncology/hematology
- 1 June 2002
Reviews of Physiology, Biochemistry and Pharmacology
- B. Keppler
- ChemistryReviews of Physiology, Biochemistry and…
- 2003
Thirty years after the onset of the first clinical studies with cisplatin, the development of antineoplastic platinum drugs continues to be a productive field of research. This article reviews the…
Antitumour metal compounds: more than theme and variations.
- M. Jakupec, M. Galanski, V. Arion, C. Hartinger, B. Keppler
- Chemistry, BiologyDalton transactions
- 14 January 2008
TLDR
Tumour-inhibiting platinum complexes--state of the art and future perspectives.
- M. Jakupec, M. Galanski, B. Keppler
- ChemistryReviews of physiology, biochemistry and…
- 2003
TLDR
KP1019, A New Redox‐Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
- C. Hartinger, M. Jakupec, B. Keppler
- Chemistry, BiologyChemistry & biodiversity
- 1 October 2008
TLDR
Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches.
- M. Galanski, M. Jakupec, B. Keppler
- Chemistry, BiologyCurrent medicinal chemistry
- 31 July 2005
TLDR
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
- Robert Trondl, P. Heffeter, C. Kowol, M. Jakupec, W. Berger, B. Keppler
- Chemistry, Biology
- 30 June 2014
TLDR
Relevance of peat-draining rivers for the riverine input of dissolved iron into the ocean.
- R. Krachler, R. Krachler, B. Keppler
- Environmental ScienceThe Science of the total environment
- 1 May 2010
KP1019, A New Redox-Active Anticancer Agent — Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
- C. Hartinger, M. Jakupec, B. Keppler
- Medicine
- 20 January 2009
From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).
- C. Hartinger, Stefanie Zorbas-Seifried, M. Jakupec, B. Kynast, H. Zorbas, B. Keppler
- Biology, MedicineJournal of inorganic biochemistry
- 1 May 2006
...
...